β¨ Medicines Consent Notices
5090 NEW ZEALAND GAZETTE, No. 174 21 DECEMBER 2006
Schedule
Product:
Arimidex
Active Ingredient:
Anastrozole 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
AstraZeneca Limited
Manufacturer:
AstraZeneca Pharmaceuticals LP, 587 Old Baltimore Pike, Newark, Delaware, United States of America
Product:
Enbrel
Active Ingredient:
Etanercept 25mg
Dosage Form:
Powder for injection
Diluent
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturers:
Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Strasse 65, Biberach an der Riss, Germany
DSM Pharmaceuticals Inc, 5900 North West Greenville Blvd., Greenville, North Carolina, United States of America
Product:
Enbrel
Active Ingredient:
Etanercept 50mg
Dosage Form:
Powder for injection
Diluent
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturer:
Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Strasse 65, Biberach an der Riss, Germany
Product:
Integrilin
Active Ingredient:
Eptifibatide 0.75mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Laboratories NV, Industriepark 30, B-2220 Heist-op-den-Berg, Belgium
Sicor Pharmaceuticals Inc., 19 Hughes Drive, Irvine, California, United States of America
Product:
Integrilin
Active Ingredient:
Eptifibatide 2mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturers:
Schering-Plough Laboratories NV, Industriepark 30, B-2220 Heist-op-den-Berg, Belgium
Sicor Pharmaceuticals Inc., 19 Hughes Drive, Irvine, California, United States of America
Product:
Rectogesic
Active Ingredient:
Glyceryl trinitrate 0.2%w/w
Dosage Form:
Rectal ointment
New Zealand Sponsor:
Health Support Limited
Manufacturer:
Mayne Pharma International Pty Ltd, 1538 Main North Road, Salisbury South, South Australia, Australia
Dated this 14th day of December 2006.
MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8858
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product:
Clean & Clear Active Clear Speed Clearing Gel
Active Ingredient:
Salicylic acid 0.5%w/w
Dosage Form:
Topical gel
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturer:
IDS Manufacturing Limited, 21/7 Moo 6, Kookot, Lamlukka, Pathumthani, Thailand
Product:
Vicks Vital Lemon Throat Lozenge
Active Ingredients:
Ascorbic acid 1.1%w/w
Menthol 0.1%w/w
Dosage Form:
Lozenge
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble GmbH, Procter & Gamble Strasse 1, 64521 Gross Gerau, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 174
Gazette.govt.nz —
NZ Gazette 2006, No 174
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare14 December 2006
Consent, Distribution, Changed Medicines, Medicines Act 1981
- MARK JACOBS, Acting Deputy Director-General, Public Health
π₯ Consent to the Distribution of New Related Products
π₯ Health & Social WelfareConsent, Distribution, New Products, Medicines Act 1981